ANI Pharmaceuticals (ANIP) Q3 2026 earnings — TrendMatrix coverage
Reported
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure · Editorial policy
Key numbers
- Adjusted EPS
- $2.70
- Estimate
- $2.18
- Surprise
- +23.8%
- Revenue (period 2026-09-30)
- $290.8M
- Score today
- 6.9/10
Revenue source: xbrl.
How the report landed
ANI Pharmaceuticals (ANIP) beat the $2.18 estimate with adjusted EPS of $2.70 — a large 23.8% upside surprise.
Where TrendMatrix's rating stands now
TrendMatrix currently rates ANIP Hold at 6.9/10; no pre/post engine snapshot brackets this report.
4 of the last 4 quarters beat the estimate; this quarter's +23.8% surprise compares with a +26.9% four-quarter average.
What supports the rating
- V7 quality resilience bonus: +0.2 (Q=7.2 in RISK_OFF)
- Sector modifier (Healthcare): +0.5
What argues against it
- Concentration risk — Supplier: single-source API per product
- Concentration risk — Supplier: Cortrophin Gel and ILUVIEN contract manufacturers
- Leverage penalty (D/E 1.0): -0.5
This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.
The levels TrendMatrix's engine tracks
- Current price
- $68.83
- Price target
- $92.03
- Stop
- $66.52
- Upside to target
- +33.7%
- Reward-to-risk
- 4.9:1
The stock trades at 15.1× trailing but 6.9× forward earnings — consensus estimates already build in a substantial earnings recovery.
Model outputs from TrendMatrix’s engine as of 2026-11-06 — shown for context, not personalized investment advice.
ANIP at TrendMatrix's latest read
Healthcare earnings trade on pipeline and payer dynamics as much as the quarter itself; a beat or miss is weighed against trial and reimbursement news.
- Industry
- Drug Manufacturers - Specialty & Generic
- Market cap
- $1.60B
- P/E (fwd)
- 6.9
- P/E (ttm)
- 15.1
- 52-week range
- $68.78–$95.45
- Off 52-week high
- 27.9%
- RSI (14)
- 37
- Volume vs avg
- 0.43×
- Score today
- 6.9/10